+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Urticaria Drug"

From
Urticaria Drugs Market 2024-2028 - Product Thumbnail Image

Urticaria Drugs Market 2024-2028

  • Report
  • January 2024
  • 167 Pages
  • Global
From
Chronic Urticaria Market Report and Forecast 2024-2032 - Product Thumbnail Image

Chronic Urticaria Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 200 Pages
  • Global
From
Chronic Urticaria Or Hives - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Chronic Urticaria Or Hives - Global Clinical Trials Review, 2024

  • Clinical Trials
  • July 2024
  • 458 Pages
  • Global
From
From
Loading Indicator

The Urticaria Drug market is a subset of the Immune Disorders Drugs market, which focuses on the treatment of allergic reactions and other immune-related conditions. Urticaria, also known as hives, is a common skin condition characterized by itchy, raised welts on the skin. Urticaria drugs are used to reduce the symptoms of the condition, such as itching, swelling, and redness. These drugs can be administered orally, topically, or intravenously, depending on the severity of the condition. Commonly used urticaria drugs include antihistamines, corticosteroids, and leukotriene receptor antagonists. Some companies in the Urticaria Drug market include GlaxoSmithKline, Sanofi, Novartis, Pfizer, and Merck. Show Less Read more